TL47: Handling protocol violations... do you use gloves?
*Daniel Cotton, Boehringer Ingelheim Pharmaceuticals, Inc 

Keywords: protocol violations, PV

As a trial sponsor, at what levels do you track, report, and analyze protocol violations? Do you report every inclusion/exclusion violation? Or only ones deemed important to patient rights and safety? What does FDA expect from sponsors? Are per-protocol analyses necessary?